BioNTech SE(BNTX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BNTX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for BioNTech SE (BNTX), a Healthcare sector company. BNTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of BNTX by reported 13-F value include FMR, PRIMECAP MANAGEMENT CO/CA/, FLOSSBACH VON STORCH SE, based on the most recent SEC filings. BNTX trades on the Nasdaq exchange and files with the SEC under CIK 1776985. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BNTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BioNTech SE directly from SEC EDGAR.
Get alerted when BNTX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for BioNTech SE including:
Top Institutional Holders of BNTX
FMR LLC
$507.4M5,709,240 shPRIMECAP MANAGEMENT CO/CA/
$337.2M3,793,711 shFLOSSBACH VON STORCH SE
$327.1M3,680,315 shDODGE & COX
$326.8M3,676,791 shBlackRock, Inc.
$147.4M1,658,153 shBNP PARIBAS FINANCIAL MARKETS
$146.8M1,651,789 shTemasek Holdings (Private) Ltd
$133.9M1,506,027 shCITADEL ADVISORS LLC
$84.6M951,372 shBANK OF AMERICA CORP /DE/
$80.3M903,029 shGSK plc
$79.1M889,824 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $507.4M | 5,709,240 |
| PRIMECAP MANAGEMENT CO/CA/ | $337.2M | 3,793,711 |
| FLOSSBACH VON STORCH SE | $327.1M | 3,680,315 |
| DODGE & COX | $326.8M | 3,676,791 |
| BlackRock, Inc. | $147.4M | 1,658,153 |
| BNP PARIBAS FINANCIAL MARKETS | $146.8M | 1,651,789 |
| Temasek Holdings (Private) Ltd | $133.9M | 1,506,027 |
| CITADEL ADVISORS LLC | $84.6M | 951,372 |
| BANK OF AMERICA CORP /DE/ | $80.3M | 903,029 |
| GSK plc | $79.1M | 889,824 |
More Healthcare Companies
View all Healthcare →Put BNTX on your watchlist
Track score changes the day BioNTech SE files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BNTX a good stock to buy?
13F Pro's AI-powered analysis of BioNTech SE (BNTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BNTX are available on the BNTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own BNTX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BNTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of BioNTech SE's investment landscape.